Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Cytokine Release Syndrome × Gelsolin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pneumonia 1 Lymphoma, Follicular 1 Cytokine Release Syndrome 1 COVID-19 1

Interventions

siltuximab 3 tocilizumab 1 talquetamab 1 obinutuzumab 1 glofitamab 1 axicabtagene ciloleucel 1 Oxaliplatin 1 Interleukin 1 Receptor Antagonist Protein 1 Gemcitabine 1 Gelsolin 1 Dexamethasone 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04358406 2023-11-28

Rhu-pGSN for Severe Covid-19 Pneumonia

BioAegis Therapeutics Inc.

Phase 2 Completed

64 enrolled 17 charts

Cytokine Release Syndrome, COVID-19, Lymphoma, Follicular, Pneumonia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡